These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 19551314)
1. Role of fibrinolytic markers in acute stroke. Abdullah WZ; Idris SZ; Bashkar S; Hassan R Singapore Med J; 2009 Jun; 50(6):604-9. PubMed ID: 19551314 [TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction. Mansfield MW; Catto AJ; Carter AM; Grant PJ Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850 [TBL] [Abstract][Full Text] [Related]
3. Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke. Haapaniemi E; Soinne L; Syrjälä M; Kaste M; Tatlisumak T Acta Neurol Scand; 2004 Oct; 110(4):242-7. PubMed ID: 15355488 [TBL] [Abstract][Full Text] [Related]
4. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147 [TBL] [Abstract][Full Text] [Related]
5. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism]. Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355 [TBL] [Abstract][Full Text] [Related]
6. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels. Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924 [TBL] [Abstract][Full Text] [Related]
7. [Activation of fibrynolysis in children with chronic B or C hepatitis]. Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691 [TBL] [Abstract][Full Text] [Related]
8. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion. Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369 [TBL] [Abstract][Full Text] [Related]
9. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease. Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383 [TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease. Nikfardjam M; Graf S; Beckmann R; Hornykewycz S; Koller-Strametz J; Binder BR; Huber K Thromb Haemost; 1999 Sep; 82 Suppl 1():80-4. PubMed ID: 10695493 [TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolytic activity in patients with acute cerebral infarction. Li F; Zhang G; Zhao W Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064 [TBL] [Abstract][Full Text] [Related]
12. The fibrinolytic system in chronic renal failure. Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527 [TBL] [Abstract][Full Text] [Related]
13. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients. Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541 [TBL] [Abstract][Full Text] [Related]
15. Genetic markers of fibrinolytic responses of older persons to exercise training. Kulaputana O; Ghiu I; Phares DA; Ferrell RE; Macko RF; Goldberg AP; Hagberg JM Int J Sports Med; 2006 Aug; 27(8):617-22. PubMed ID: 16874588 [TBL] [Abstract][Full Text] [Related]
16. Questioning a class effect: does ACE inhibitor tissue penetration influence the degree of fibrinolytic balance alteration following an acute myocardial infarction? Tsikouris JP; Suarez JA; Meyerrose GE; Ziska M; Fike D; Smith J J Clin Pharmacol; 2004 Feb; 44(2):150-7. PubMed ID: 14747423 [TBL] [Abstract][Full Text] [Related]
17. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597 [TBL] [Abstract][Full Text] [Related]
18. [Tissue plasminogen activator (t-PA) in aqueous humor of patients with cataract]. Kotschy M; Kałuzny J; Kaniasty M; Zekanowska E; Kropińska E Klin Oczna; 1996 Mar; 98(3):201-3. PubMed ID: 9019589 [TBL] [Abstract][Full Text] [Related]
19. A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation. Crookston KP; Marsh CL; Chandler WL Blood Coagul Fibrinolysis; 2000 Jan; 11(1):79-88. PubMed ID: 10691102 [TBL] [Abstract][Full Text] [Related]
20. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis. Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]